Price
Target price
€36.80
€36.80
3.410%
1.2
3.410%
€49.36
08.10.25 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Agios Pharmaceuticals Inc. Stock
A very strong showing by Agios Pharmaceuticals Inc. today, with an increase of €1.20 (3.410%) compared to yesterday's price.
We see a rather positive sentiment for Agios Pharmaceuticals Inc. with 7 Buy predictions and 1 Sell predictions.
With a target price of 49 € there is a positive potential of 33.15% for Agios Pharmaceuticals Inc. compared to the current price of 36.8 €.
So far the community has only identified positive things for Agios Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 3.410% | 7.602% | 18.710% | -0.541% | 15.723% | 31.429% | 19.870% |
| Ironwood Pharmaceuticals | 0.000% | 6.667% | 34.737% | -65.591% | -69.524% | -87.607% | -85.287% |
| Novocure Ltd | 1.480% | 3.696% | 15.212% | -7.597% | -57.606% | -85.214% | -88.772% |
| Iovance Biotherapeutics Inc. | 5.470% | 3.156% | -3.517% | -77.989% | -71.793% | -80.594% | -92.216% |
Comments
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $56.00 price target on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Bank of America Corporation from $52.00 to $51.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $58.00 price target on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
News
Agios (AGIO) Q2 Revenue Jumps 45%
Agios Pharmaceuticals (NASDAQ:AGIO), a biotechnology company focused on therapies for rare blood disorders, released its second quarter 2025 earnings on July 31, 2025. The headline was a notable
